This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2023
  • /
  • 11
  • /
  • Medtronic launches Penditure LAA exclusion system ...

Medtronic launches Penditure LAA exclusion system in the United States

Read time: 1 mins
Published:29th Nov 2023

Medtronic announced the United States launch of the Penditure left atrial appendage (LAA) exclusion system, an implantable clip preloaded on a single-use delivery system for LAA management during concomitant cardiac surgery procedures

The American College of Cardiology, American Heart Association, and Society of Thoracic Surgeons guidelines recommend that patients with preoperative atrial fibrillation undergoing concomitant cardiac surgery should have their LAA closed to reduce stroke risk.

According to the company, the Penditure clip is curved to match atrial anatomy and does not include fabric for atraumatic closure and reduced inflammation. It is designed to be recaptured, repositioned, and redeployed after initial deployment during a procedure.

Medtronic acquired the device technology from Syntheon LLC in August 2023 to expand its cardiac surgery profile to include LAA management.

The Penditure LAA Exclusion System received a 510k clearance in August 2023 and is commercially available in the US on a limited basis at this time.

Condition: Atrial Fibrillation
Type: drug

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.